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ABSTRACT
Objective: To assess the indications and limits of laparo-
scopic myomectomies (LM).
Methods: We conducted a retrospective analysis of 89
consecutive cases of LM. Our LM procedures were as fol-
lows: Diluted vasopressin was injected into the myoma
capsule, and a transverse incision was made by fine
monopolar electrode. Traction was applied to the
myoma with a myoma screw. The uterine wall was
sutured with a curved needle. Fibrin glue spray was
applied to prevent adhesion formation. Enucleated
myomas were removed via trocar by using an electric
morcellator. 
Results: We enucleated 195 nodules with diameters > 2
cm; the mean size of the dominant myomas was 5.3 cm.
The mean number of myomas removed from each
patient was 2. The uterine wall was sutured in all cases
with a mean of 9 sutures. The mean blood loss was 102
mL, and the mean operating time was 111 minutes. No
patients were converted to laparotomy. The average hos-
pital stay was 2.4 days. When the myomas were larger
than 10 cm, the blood loss and operating time were
increased. However, the number of myomas did not cor-
relate with blood loss. 
Conclusion: LM appears to offer a number of advan-
tages if the myoma is not larger than 10 cm.
Key Words: Laparoscopic myomectomy, Surgical tech-
nique, Indication, Limitation.
INTRODUCTION
Recently, the primary approach in young patients with
large or symptomatic myomas who desire a future preg-
nancy has been laparotomy. However, in select cases,
laparoscopic myomectomy (LM) has been reported to be
an effective technique that is associated with the devel-
opment of operative laparoscopic equipment and surgi-
cal techniques.1,2 The technical difficulties of LM are con-
trolling bleeding during the enucleation phase of
myomectomy, reapproximation of the uterine wall with
suturing techniques, and extraction of solid myomas
from the abdominal cavity. The benefit of LM and the
indication and limitations of laparoscopic myomectomy
as a routine treatment are not obvious. The purpose of
this study was to assess the limitations, feasibility, risks,
and benefits of LM. 
MATERIALS AND METHODS
From January 1998 to December 1999, 112 pre-
menopausal women underwent LM. In 13 of these
women, the myomas were < 3 cm; and in 10, the
myomas were pedunculated. These 23 women were
excluded from this study. Only those patients with sub-
mucosal, intramural, and subserosal myomas larger than
3 cm (n=89) were included in this study.
For these 89 patients, the indications for the myomecto-
my, which were sometimes all present in the same
patient, were as follows: infertility (n=40; 36.4%); chron-
ic pelvic pain (n=10; 9.1%); severe menometrorrhagia
(n=11; 10%); dysmenorrhea (n=24; 21.8%); compression
syndrome (n=16; 14.5%); or adnexal mass (n=9; 8.2%).
The average age of the patients was 35.2 ± 5.6 years
(range 19 to 52). In all patients, the presence of a myoma
was confirmed clinically by pelvic and transvaginal ultra-
sonographic examination. The size of the myoma was
measured by ultrasound with myoma size ranging from
3 cm to 16 cm. In 80 patients, the location of the myomas
was evaluated by MRI. Gonadotropin releasing hormone
agonists (GnRHa) were prescribed in 61 cases (68.5%).
Treatment consisted of intramuscular deposit of leupro-
lide acetate (Leuprin 1.88; Takeda, Osaka, Japan) or
buserelin acetate (Suprecur MP; Aventis Pharma, Tokyo,
Japan), administered once a month for 3 to 6 months.
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This preoperative treatment was used for large myomas
(>5 cm), anemia, or complicated endometriosis. 
Laparoscopic Technique
Anesthesia and Preoperative Settings: All procedures were
performed with the patient under general anesthesia. The
patients were prepared for lithotomy, and the Uterine
ManipulatorTM (Ethicon, Tokyo, Japan) was placed into
the uterine cavity for mobilization of the uterus. 
Positioning of the Trocar (Figure 1): The laparoscopic
procedures were performed with the closed method.
After pneumoperitoneum was established, a 10-mm
scope was inserted periumbilically. Three additional
puncture sites were made as follows: two 5-mm sites 2
cm above the anterior superior iliac supine; and a 10-mm
site 3 cm above the umbilicus on the left anterior axial
line, an ideal laparoscopic position providing a large
operative field. The operator stood on the patient’s left
side, controlling the 10-mm trocar with his right hand,
and manipulating the left lower 5-mm trocar with his left
hand. 
Figure 1. The sites of trocar insertion and position of the operator. The 10-mm trocar in the left upper quadrant is controlled by the
right hand; the left lower 5-mm trocar is manipulated by the left hand.
Figure 2. The myoma is kept in place centrally in the operating
field by using the Uterine manipulator˛ and myoma screw to
control it. The uterus is manipulated in the retroverted position
for an anterior myoma (A) and in the anteverted position for a
posterior myoma (B).
10 mm
5 mm
scope
monitorSurgical Procedure
All procedures were performed by the same surgeon
(HT) using a similar technique. Vasopressin was injected
between the myometrium and myoma capsule at a con-
centration of 20 IU/100 mL diluted saline solution prior
to excision to reduce the size of the blood vessels and
bleeding. The second assistant controlled the uterine
manipulator, using an anteverted position for a posterior
myoma, or retroverted position for an anterior myoma.
The myoma was maintained in a central area of the oper-
ation field (Figure 2). A horizontal incision was usually
made with a monopolar needle. A grasping forceps,
monopolar needle, and myoma screw inserted into the
left upper trocar port were used to remove the myoma
from its capsule. Traction on the myoma, combined with
use of the uterine manipulator and myoma screw, facili-
tated dissection. After the myoma had been enucleated,
hemostasis of the uterine bed was completed with a
monopolar needle.
The uterine wall was sutured from 1 to 3 layers, accord-
ing to the depth of the hysterotomy. A 5-mm needle
holder with 2/0 Vicryl (Ethicon, Tokyo, Japan) was used
to reconstruct the perimetrium with a separate stitch.
Sutures are normally placed every 5 mm along the hys-
terotomy. The edges of the serosa were reapproximated
with a baseball suture by EndostitchTM (Auto Suture
Tokyo, Japan). Almost all myomas were extracted from
the abdominal cavity with the electric morcellator (Karl
Storz, Tokyo, Japan). Fibrin glue spray (Aventis Pharma,
Tokyo, Japan) was used to prevent postoperative adhe-
sion formation. Forty-one patients underwent one or
more additional surgical procedures at the time of
myomectomy including cystectomy (n=31); lysis of com-
plete cul-de-sac obliteration (n=6); salpingostomy (n=5);
and salpingo-oophorectomy (n=3).
Data were statistically evaluated with the Statistics
Package for Social Sciences (SPSS) 10.0 program for
Windows (SPSS Inc., Chicago, USAIL). The operating
times and estimated blood loss were compared with
analysis of variance (ANOVA) based on myoma location.
The correlation between operation time, estimated blood
loss, dominant myoma size, and the number of removed
myomas were determined with the Spearman rank
method. Statistical significance was assessed based on
P<0.05 and a 2-tailed test.
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RESULTS
Laparoscopy was used to enucleate 191 myomas >2 cm
in diameter. Of these, 114 myomas were intramural, 75
subserosal, and 7 submucosal. The mean number of
removed myomas per patient was 2.2± 1.7 (range, 1 to
9). The number of myomas per patient was 2 (14 cases,
15.7%), 3 (10 cases, 11.2%), and 4 or more (17 cases,
19.2%). The mean size of the dominant myomas was 5.4±
2.3 cm (range, 3.0 to 16). The myoma size was <5 cm in
43 cases (48.3%), between 5 and 10 cm in 42 cases
(47.2%), and >10 cm in 4 cases (4.5%). The largest
myoma enucleated was intramural in 59 cases (66.3%),
subserosal in 23 cases (25.8%), and submucosal in 7
cases (7.9%). The dominant myoma removed was locat-
ed in the posterior wall in 42 cases (47.2%), in the ante-
rior wall in 31 cases (34.8%), at the fundus in 14 cases
(15.7 %), and in the broad ligament in 2 cases (2.3%).
The uterine wall was sutured in all cases with a mean
suturing number (except when using the EndostitchTM
suture) of 9.7 (range, 1 to 30). A double layer suture was
necessary in 37 cases (41.6%), and more than 3 layers
were necessary in 22 cases (24.7%). An endometrial per-
foration occurred during enucleation in 6 of 7 patients
with submucosal myomas. The endometrial layer was
sutured with 3/0 Vicryl via laparoscopy.
The mean operative time was 111 ± 40 minutes (range,
50 to 270). Morcellation time for the myomas was 14 ±
20 minutes (range, 5 to 125). The mean weight of enu-
cleated myomas was 87.2 ± 136 grams (range, 10 to
1040). None of the patients required a laparotomy. The
estimated blood loss in 89 patients was between 10 and
2500 mL, with a mean of 102 mL. A blood transfusion
was required in only 1 patient.
By far, the longest operative time of 270 minutes and the
greatest blood loss of 2500 mL occurred in a patient who
had a huge intramural myoma 16 cm in diameter, locat-
ed anteriorly. The weight of the enucleated myoma was
1040 grams. Bleeding from the uterine wall could not be
controlled during suturing despite vasopressin injection,
and the extraction time was greater than 120 minutes
despite the use of an electric morcellator.
Surgical complications were limited to two cases of post-
operative fever greater than 38°C after the first 24 hours,
and these cases were treated with antibiotics. In both cases,
perioperative difficulties had occurred, and a 10-cm and a
16-cm myoma, respectively, were enucleated by LM.The Indications, Surgical Techniques, and Limitations of Laparoscopic Myomectomy, Takeuchi H et al.
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The duration of postoperative hospitalization ranged
from 2 to 7 days, with a mean of 2.4 days.
During follow-up 6 months after surgery, 10 pregnancies
occurred out of the 34 infertile patients. Four ended with
a vaginal delivery at term, and one with a submucosal
myoma was delivered by Cesarean. Two pregnancies
resulted in first trimester miscarriages. Spontaneous uter-
ine rupture was not observed in any of the pregnancies
or at delivery.
Regarding the correlation calculated between operative
time, estimated blood loss, the dominant myoma diame-
ter, and the number of myomas, the results can be sum-
marized as follows: Operative time was significantly pos-
itively correlated (P<0.01) with the dominant myoma
diameter and the number of myomas; estimated blood
loss was significantly positively correlated with myoma
size (P<0.01), but no correlation existed with the number
of myomas (Figure 3). Operative time and estimated
blood loss were not significantly related to the location
(anterior, posterior, fundus, and in the broad ligament) of
the myoma (Figure 4).
In this study, the risk of perioperative heavy bleeding
(> 500 mL) did not correlate with the number of
myomectomies, or the location of the dominant myoma
that was removed. The risk of heavy bleeding is a sig-
nificant correlate with largest myoma size. When the
Figure 3. Relationship between dominant myoma diameter and operative time and estimated blood loss (A, B) and between the num-
ber of myoma and operative time and estimated blood loss (C, D).myoma is larger than 10 cm, the blood loss and opera-
tive time are estimated to be greater. A limit of 10 cm has
been proposed as the maximum size for LM. 
DISCUSSION
Among the laparoscopic operations carried out in the
field of gynecology, LM is fraught with problems.
Solutions, including those involving the enucleation of
the myoma, suturing of the myometrium, and the recov-
ery of solid myomas from the body of the uterus, and the
indications for and limitations of LM have not been clear-
ly defined. The points of prime importance in perform-
ing effective laparoscopic enucleation of myomas from
various sites and depths in the uterus, ensuring that the
suturing of the myometrium is complete, and that the
myoma is fully extracted, are where the operator stands
and where the point of the trocar is inserted. Our
method, in which the operator stands on the left side of
the patient and controls a left upper-quadrant trocar (10
mm) and a left lower-quadrant trocar (5 mm) by his or
her right and left hands, respectively, seems to be appro-
priate for achieving our purpose in LM. Because the for-
ceps are manipulated through an upper-quadrant trocar
by the operator’s right hand, traction of the myoma and
suturing of the myometrium using a myoma screw are
facilitated. Koh et al3 also has stated that, when laparo-
scopic suturing is performed, the use of ipsilateral upper
and lower trocars permits the prompt and fatigue-free
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operation of forceps, unlike the use of right and left tro-
cars by crossing one of the operator’s hands with the
scope. When LM is performed, the use of vasopressin is
effective, because bleeding from the wound surface dur-
ing enucleation obstructs the view of the operative field,
making enucleation and suturing difficult. The myoma is
turned a pale color by the vasoconstrictor action that
immediately follows the local administration of vaso-
pressin between the myometrium and the capsule of the
myoma.4 This effect persists for 20 to 30 minutes. The
capsule of the nucleus should be incised and detached
on the surface from the myometrium to achieve a suc-
cessful myomectomy, and for this purpose, it is impor-
tant to draw the capsule of the myoma perpendicularly
from the myometrium. Because the traction can be per-
formed only through the insertion point of a trocar in LM,
the procedure is extremely limited compared with tech-
niques using laparotomy in which the traction of a
myoma can be performed in any direction. The apical
chip of the Uterine ManipulatorTM can move 90 degrees
rearwards and 120 degrees forwards. When a myoma
nucleus is present in the anterior wall, the uterus should
be kept in a retroflexed position; and when it is in the
posterior wall, the uterus should be kept in an anteflexed
position. The myoma nuclei can then be drawn perpen-
dicularly to the long axis of the uterus through a left
upper quadrant trocar by using a myoma screw.
Enucleation of myoma from any site, including the ante-
rior wall, the posterior wall, the fundus and the broad lig-
Figure 4. The operative time and estimated blood loss among the dominant myoma locations (A: anterior, P: posterior, F: fundus).The Indications, Surgical Techniques, and Limitations of Laparoscopic Myomectomy, Takeuchi H et al.
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ament, can be carried out using this procedure. Rossetti
et al5 made an articulated myoma drill whose tip can be
bent at a right angle to design the traction method for
myoma nuclei, but our methods in which the direction of
traction by a myoma screw is fixed while the uterine
position is adjusted by a Uterine ManipulatorTM appears
easier than theirs. 
Either a longitudinal or a transverse hysterotomy of the
uterine wall can be performed for myomectomy,6 but we
perform only the latter, irrespective of the site of the
myoma, because suturing toward the long axis of the
uterus in our method, in which a needle holder is oper-
ated through a left upper quadrant trocar, is easy.
Igarashi7 has proposed that a transverse incision of the
uterus and suturing of the myometrium toward the long
axis of the uterus should be performed, on the basis of
the hemodynamics of the myometrium, in which the
arcuate artery from the ascending branch of the uterine
artery crosses the uterine body and the radial artery
branches from the arcuate artery to the uterine
endometrium. The suturing of the myometrium in LM
requires the greatest degree of skill, but it can be per-
formed smoothly and easily by our method, because the
needle holder can be controlled by the operator’s right
hand through the left upper quadrant trocar, which has
extensive working space. Laparoscopic suturing can be
performed similarly to suturing in laparotomy if the oper-
ator is familiar with the suturing technique, and we usu-
ally suture the myometrium with an average of 9 stitches,
although more than 20 are necessary in some cases.
Myomectomy aims to preserve fertility, and the preven-
tion of postoperative adhesions that reduce fertility is
important. The baseball suture, in which the incised layer
is embedded, is adequate for suturing between superficial
myometrium and serosa. It is difficult to perform a
laparoscopic baseball suture with a common curved nee-
dle, but it can be performed easily and quickly with the
EndostitchTM. The EndostitchTM is a suturing device to
which the mechanism of a hand sewing machine is
applied and in which a straight, certainly threaded nee-
dle shuttles to and fro through an apical jaw. Thus, the
baseball suture can be easily performed without chang-
ing hands. Furthermore, the wound surface is coated with
fibrin glue spray to prevent postoperative adhesion.
Fibrin glue is effective not only as a hemostatic, but also
in preventing adhesion, because the wound surface is
covered with a gelatinous capsule for about 1 week until
the completion of primary healing in vivo. The prophy-
lactic effect of the glue against postoperative adhesion
has been confirmed by SLL in the enucleation of ovarian
endometrioma.8 
The extraction of enucleated myoma from the uterine
body is one of the primary limiting factors in LM, and
various extraction methods have been designed. We
have performed internal crushing and recovery by colpo-
tomy, and when the diameter of a myoma nucleus is 5
cm or over, the recovery time is extremely long. An elec-
tric morcellator has been adopted, so that a large myoma
can also be extracted through a trocar site.
As the result of improvements in these surgical proce-
dures and of the development of new devices, the indi-
cations for LM have been significantly broadened. Of 89
patients who underwent LM from 1998 to 1999, none
were converted to laparotomy. In a study on the amount
of bleeding and the time required for surgery, a positive
correlation between the size of the myoma and both the
time required for surgery and the amount of bleeding
were observed, but the number of myomas showed a
positive correlation only with the duration of the opera-
tion. If the diameter of a myoma is ≥10 cm, the time
required for suturing and extraction will be significantly
prolonged, and the risk of loosing more than 500 mL of
blood will be increased. Dubuisson et al9 divided the
patients undergoing LM into 2 groups, one completing
LM alone and the other requiring postoperative laparoto-
my. They studied the indications for LM and reported
that LM was indicated in 1 or 2 myoma nuclei of 8 cm or
less in diameter. In addition, Maris et al10 reported that
the requirements for the safe performance of LM are a
myoma size of 7 cm or less with no more than 5 total.
The present study revealed that a limiting factor of LM is
the size of the myoma nucleus and that LM seems to be
indicated in myomas of 10 cm or less in diameter. As for
the number of myomas, specific criteria have not been
established; but if the maximum diameter of the myomas
is 5 cm or less, LM seems to be indicated for up to 5
myomas. Furthermore, Dubuisson et al9 reported that, if
myomas are present in the anterior wall, the risk of need-
ing laparotomy is increased, but the present study
showed that the sites of the myomas do not affect the
time required for operation or the amount of bleeding
and indicated that our method can be applied to myomas
at any site. In addition, preoperative GnRHa administra-
tion reduces the size of the myoma and decreases the
blood flow in the uterine artery, so that the indications
for LM are extended, the operative procedure becomeseasier, and the amount of bleeding is decreased.11 In this
study, 36 patients (63.2%) were given GnRHa preopera-
tively, and GnRHa’s usefulness in LM was confirmed.
LM has the common merits of laparoscopic operations,
such as less operative stress and a shorter postoperative
recovery than that of laparotomy. In addition, it has also
been reported that the preservation of fertility after LM is
superior to that after laparotomy because less postoper-
ative adhesions occur in LM than in laparotomy.12,13 In
this study, the postoperative hospitalization period was
approximately 2 days, and 10 (29.4%) of 34 infertile
patients became pregnant. Four patients who had
already delivered vaginally had intramural myomas, and
only 1 patient with a submucosal myoma required a
Cesarean delivery. Rupture of the uterus14 in pregnancy
and at delivery as a result of the failure of the myometri-
al suture, which was first reported soon after the intro-
duction of LM, seems to have been overcome by ensur-
ing complication of the suturing. Unlike laparotomy, LM
has the shortcoming of difficulty in diagnosing small
myomas deep in the myometrium by palpation of the
uterine body, so that these may be missed in LM. It has
also been reported that the recurrence rate of myomas is
higher in LM than in laparotomy.15  When LM is per-
formed in multiple myomas, it is important to know pre-
cisely the sites of the myoma by preoperative diagnostic
imaging techniques, such as MRI.
LM is being established as one of the basic laparoscopic
operative techniques in the field of gynecology, and fur-
ther study of its indications and long-term prognosis is
expected.
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